(Q39670176)

13 September 2017

1 reference

title

Antifungal agents in dermatology. (English)

1 reference

13 September 2017

Lesher JL Jr

1

1 reference

13 September 2017

Smith JG Jr

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 September 1987

1 reference

Journal of the American Academy of Dermatology

13 September 2017

published in

1 reference

13 September 2017

volume

17

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

383-394

1 reference

Treatment of tinea versicolor with sulfur-salicylic shampoo

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Rapid Treatment of Tinea Versicolor With Selenium Sulfide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Double-blind efficacy study of selenium sulfide in tinea versicolor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

New uses for benzoyl peroxide: a broad-spectrum antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

A clinical double-blind trial of topical haloprogin and miconazole against superficial fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Clotrimazole vs Haloprogin Treatment of Tinea Cruris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Fungal Sterols and the Mode of Action of the Polyene Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Laboratory and clinical studies on candidiasis in the newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Antifungal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Antifungal Agents Used in Systemic Mycoses Activity and Therapeutic Use

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Strategies in the treatment of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Mode of action of 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

The current status of systemic antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Dermatitis herpetiformis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

The treatment of dermatomycoses with orally administered griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Fat contents of meals and bioavailability of griseofulvin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Griseofulvin levels in stratum corneum. Study after oral administration in man

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Mycological and clinical evaluation of griseofulvin for chronic onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

The mechanism of action of the new antimycotic ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

A clinical double-blind trial of topical miconazole and clotrimazole against superficial fungal infections and erythrasma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Econazole: a review of its antifungal activity and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

High-Dose Ketoconazole for Treatment of Fungal Infections of the Central Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

The treatment of patients with chronic mucocutaneous candidosis and Candida onychomycosis with ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Efficacy of Ketoconazole v Nystatin in Prevention of Fungal Infections in Neutropenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Localized cutaneous cryptococcosis successfully treated with ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Oral ketoconazole for dermatophyte infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole in griseofulvin-resistant dermatophytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Treatment of chronic dermatophyte infections. The use of ketoconazole in griseofulvin treatment failures

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Improvement of Psoriasis of the Scalp With Ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Response of the cutaneous lesions of Reiter's syndrome to ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole's inhibition of fungal antigen-induced thymidine uptake by lymphocytes from patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Comparison of ketoconazole and amphotericin B in interference with thymidine uptake by and blastogenesis of lymphocytes stimulated with Histoplasma capsulatum antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Chronic Mucocutaneous Candidiasis with a Serum-Dependent Neutrophil Defect: Response to Ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole Blocks Adrenal Steroid Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole-induced drop in serum and saliva testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

High-Dose Ketoconazole Therapy and Adrenal and Testicular Function in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Inhibition of cholesterol synthesis by ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Impairing effect of food on ketoconazole absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Disposition of ketoconazole, an oral antifungal, in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Orally administered ketoconazole: route of delivery to the human stratum corneum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Antifungal drug susceptibility testing. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Potentiation of oral anticoagulants by ketoconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Laboratory and clinical assessment of ketoconazole in deep-seated mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Interaction of Ketoconazole with Rifampin and Isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole, cyclosporin metabolism, and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole, cyclosporin, and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ketoconazole-cyclosporin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Hepatic reactions during ketoconazole treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

A comparison between one and two weeks' treatment with bifonazole in pityriasis versicolor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

A comparative study of once versus twice daily treatment of superficial dermatophyte and yeast infections with tioconazole (1%) cream

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Terconazole - a new broad-spectrum antifungal.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Treatment of chromomycosis with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

In vivo antimycotic activity of naftifine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970218-7

7 January 2021

10.1016/S0190-9622(87)70218-7

Identifiers

DOI

1 reference

13 September 2017

1 reference